Skip to content

Investing
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

Search

SEARCH FOR AN ARTICLE

Search

Investing
Featured
Market
Biotech
Oil & Gas
Financial
Health
MORE
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Industrials
- Food & Beverage

HomeNYSE:ABBV

NYSE:ABBV

AbbVie’s Teliso-V Shows Promise in Lung Cancer Study

AbbVie’s Teliso-V Shows Promise in Lung Cancer Study

November 30, 2023

Safeguarding Revenues After Humira Patent Expiry: AbbVie’s Strategy

Safeguarding Revenues After Humira Patent Expiry: AbbVie’s Strategy

August 24, 2023

Abbvie Stock Gains on Q4 Earnings Beat

Abbvie Stock Gains on Q4 Earnings Beat

February 14, 2023

LATEST NEWS

Investing Leisure Products Stocks Q2 Earnings Insights
Investing Ford’s US Sales Jump 11.2% in May, Fueled by Hybrids, Trucks, and EVs
Investing Apple’s Generative AI Push: No iPhone Supercycle Expected in 2024
Investing Nvidia’s Market Value Nears Apple’s Amid Record Highs
Investing Verizon Adds Peacock, Offers Discounted YouTube Premium

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Stock Street News.

I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

Market Jar Media Inc. © 2024